Exact Mass: 432.0545

Exact Mass Matches: 432.0545

Found 23 metabolites which its exact mass value is equals to given mass value 432.0545, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Mollicellin F

6-chloro-5,12-dihydroxy-7,15,15,19-tetramethyl-9,17-dioxo-2,10,14-trioxatetracyclo[9.8.0.0³,⁸.0¹³,¹⁸]nonadeca-1(11),3,5,7,12,18-hexaene-4-carbaldehyde

C21H17ClO8 (432.0612)


Mollicellin F is classified as a Food Contaminant (code WG) in the DFC.

   

lamotrigine-2-N-glucuronide

3,5-diamino-2-[(2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]-6-(2,3-dichlorophenyl)-1,2lambda5,4-triazin-2-ylium

C15H16Cl2N5O6 (432.0478)


lamotrigine-2-N-glucuronide is a metabolite of lamotrigine. Lamotrigine, marketed in the US and most of Europe as Lamictal by GlaxoSmithKline, is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is also used as an adjunct in treating depression, though this is considered off-label usage. For epilepsy, it is used to treat focal seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. (Wikipedia)

   

Rivulobirin B

Rivulobirin B

C23H12O9 (432.0481)


   

1-(2,4-Dichlorophenyl)-2-(1-imidazolyl)ethanol glucuronide

1-(2,4-Dichlorophenyl)-2-(1-imidazolyl)ethanol glucuronide

C17H18Cl2N2O7 (432.0491)


   

mollicellin F

6-chloro-5,12-dihydroxy-7,15,15,19-tetramethyl-9,17-dioxo-2,10,14-trioxatetracyclo[9.8.0.0^{3,8}.0^{13,18}]nonadeca-1(19),3(8),4,6,11,13(18)-hexaene-4-carbaldehyde

C21H17ClO8 (432.0612)


A member of the class of depsidones that is 3,4-dihydro-H,11H-chromeno[6,7-b][1,4]benzodioxepine substituted by a chloro group at position 9, hydroxy groups at positions 8 and 13, methyl groups at positions 2, 2, 5 and 10, oxo groups at positions 4 and 11 and a formyl group at position 7. Isolated from Chaetomium brasiliense, it exhibits cytotoxic activity.

   

Triphenyl(propyl)phosphonium iodide

Triphenyl(propyl)phosphonium iodide

C21H22IP (432.0504)


   

N-[[5-(1H-pyrazol-5-yl)-1,3,4-thiadiazol-2-yl]methyl]-4-(2,4,6-trifluorobenzoyl)-1H-pyrrole-2-carboxamide

N-[[5-(1H-pyrazol-5-yl)-1,3,4-thiadiazol-2-yl]methyl]-4-(2,4,6-trifluorobenzoyl)-1H-pyrrole-2-carboxamide

C18H11F3N6O2S (432.0616)


   

Isopropyltriphenylphosphonium iodide

Isopropyltriphenylphosphonium iodide

C21H22IP (432.0504)


   

Benzyltriphenylphosphonium bromide

Benzyltriphenylphosphonium bromide

C25H22BrP (432.0642)


   

9-Bromo-10-(9-phenanthryl)anthracene

9-Bromo-10-(9-phenanthryl)anthracene

C28H17Br (432.0514)


   

Padsevonil

Padsevonil

C14H14ClF5N4O2S (432.0446)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Lamotrigine N2-glucuronide

Lamotrigine N2-Glucuronide 85

C15H16Cl2N5O6+ (432.0478)


   

Pamoic acid disodium

Pamoic acid disodium

C23H14Na2O6 (432.0586)


Pamoic acid disodium is a potent GPR35 agonist with an EC50 value of 79 nM. Pamoic acid disodium induces GPR35 internalization and activates ERK1/2 with EC50 values of 22 nM and 65 nM, respectively. Pamoic acid disodium potently recruits β-arrestin2 to GPR35 and has an antinociceptive effect[1].

   

2-{[(5-{4-Chloro-3-nitrophenyl}-2-furyl)methylene]amino}-3-(2-furyl)imidazo[1,2-a]pyridine

2-{[(5-{4-Chloro-3-nitrophenyl}-2-furyl)methylene]amino}-3-(2-furyl)imidazo[1,2-a]pyridine

C22H13ClN4O4 (432.0625)


   

N-(5-chloro-2-oxo-3-indolyl)-2-thiophen-2-yl-4-quinolinecarbohydrazide

N-(5-chloro-2-oxo-3-indolyl)-2-thiophen-2-yl-4-quinolinecarbohydrazide

C22H13ClN4O2S (432.0448)


   

1-[[4-(6-Chloro-3-pyridinyl)phenyl]methyl]-5-(trifluoromethoxy)indole-2,3-dione

1-[[4-(6-Chloro-3-pyridinyl)phenyl]methyl]-5-(trifluoromethoxy)indole-2,3-dione

C21H12ClF3N2O3 (432.0489)


   

2-[(4,6-dioxo-5-phenyl-1,4,5,6-tetrahydropyrimidin-2-yl)sulfanyl]-N-(4-sulfamoylphenyl)acetamide

2-[(4,6-dioxo-5-phenyl-1,4,5,6-tetrahydropyrimidin-2-yl)sulfanyl]-N-(4-sulfamoylphenyl)acetamide

C18H16N4O5S2 (432.0562)


   

Ethyl 2-[(4-fluorobenzoyl)carbamothioylamino]-4-(5-methylfuran-2-yl)thiophene-3-carboxylate

Ethyl 2-[(4-fluorobenzoyl)carbamothioylamino]-4-(5-methylfuran-2-yl)thiophene-3-carboxylate

C20H17FN2O4S2 (432.0614)


   

8-{(2E)-2-[(2Z)-2-bromo-3-phenylprop-2-en-1-ylidene]hydrazinyl}-6-hydroxy-7-(2-hydroxyethyl)-3-methyl-3,7-dihydro-2H-purin-2-one

8-{(2E)-2-[(2Z)-2-bromo-3-phenylprop-2-en-1-ylidene]hydrazinyl}-6-hydroxy-7-(2-hydroxyethyl)-3-methyl-3,7-dihydro-2H-purin-2-one

C17H17BrN6O3 (432.0545)


   

(2S,3S,4S,5R)-6-[3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16Cl2N5O6+ (432.0478)


   

6-chloro-5,12-dihydroxy-7,15,15,19-tetramethyl-9,17-dioxo-2,10,14-trioxatetracyclo[9.8.0.0³,⁸.0¹³,¹⁸]nonadeca-1(19),3,5,7,11,13(18)-hexaene-4-carbaldehyde

6-chloro-5,12-dihydroxy-7,15,15,19-tetramethyl-9,17-dioxo-2,10,14-trioxatetracyclo[9.8.0.0³,⁸.0¹³,¹⁸]nonadeca-1(19),3,5,7,11,13(18)-hexaene-4-carbaldehyde

C21H17ClO8 (432.0612)


   

(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione

(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione

C19H16N2O6S2 (432.045)


   

9-({9-hydroxy-7-oxofuro[3,2-g]chromen-4-yl}oxy)-4-methoxyfuro[3,2-g]chromen-7-one

9-({9-hydroxy-7-oxofuro[3,2-g]chromen-4-yl}oxy)-4-methoxyfuro[3,2-g]chromen-7-one

C23H12O9 (432.0481)